Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.

From February 10, 2022 to March 31, 2022, the company has repurchased 16,669 shares, representing 0.13% for KRW 1,588.58 million. With this, the company has completed the repurchase of 16,669 shares, representing 0.13% for KRW 1,588.58 million under the buyback announced on February 10, 2022.